Mark Okey Decker, Jr. Buys 8,000 Shares of Global Medical REIT (NYSE:XRN) Stock

Global Medical REIT Inc. (NYSE:XRN) CEO Mark Okey Decker, Jr. acquired 8,000 shares of Global Medical REIT stock in a transaction on Monday, August 10th. The shares were bought at an average cost of $35.88 per share, for a total transaction of $287,040.00. Following the completion of the transaction, the chief executive officer owned 67,774 shares in the company, valued at approximately $2,431,731.12. This trade represents a 13.38% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Global Medical REIT Stock Up 0.7%

Shares of NYSE XRN opened at $36.52 on Friday. The firm has a fifty day simple moving average of $36.59 and a two-hundred day simple moving average of $35.80. Global Medical REIT Inc. has a 12 month low of $29.05 and a 12 month high of $39.93. The company has a current ratio of 0.68, a quick ratio of 0.68 and a debt-to-equity ratio of 1.68. The firm has a market capitalization of $483.50 million, a PE ratio of 9.82 and a beta of 1.09.

Global Medical REIT (NYSE:XRN) last announced its earnings results on Wednesday, August 5th. The company reported $4.78 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $3.95. Global Medical REIT had a net margin of 36.82% and a return on equity of 13.74%. The firm had revenue of $39.75 million for the quarter. Equities analysts expect that Global Medical REIT Inc. will post 3.06 earnings per share for the current year.

Institutional Trading of Global Medical REIT

Several institutional investors have recently bought and sold shares of the company. Marshall Wace LLP raised its holdings in Global Medical REIT by 0.8% in the fourth quarter. Marshall Wace LLP now owns 38,244 shares of the company’s stock worth $1,290,000 after buying an additional 308 shares during the last quarter. Daiwa Securities Group Inc. grew its holdings in shares of Global Medical REIT by 7.4% during the fourth quarter. Daiwa Securities Group Inc. now owns 4,827 shares of the company’s stock valued at $163,000 after buying an additional 332 shares during the last quarter. Fifth Third Bancorp grew its holdings in shares of Global Medical REIT by 35.3% during the fourth quarter. Fifth Third Bancorp now owns 1,417 shares of the company’s stock valued at $48,000 after buying an additional 370 shares during the last quarter. Caitong International Asset Management Co. Ltd increased its position in shares of Global Medical REIT by 1,001.4% during the third quarter. Caitong International Asset Management Co. Ltd now owns 793 shares of the company’s stock valued at $27,000 after acquiring an additional 721 shares in the last quarter. Finally, Virtus Advisers LLC increased its position in shares of Global Medical REIT by 46.5% during the fourth quarter. Virtus Advisers LLC now owns 2,418 shares of the company’s stock valued at $82,000 after acquiring an additional 768 shares in the last quarter. 57.52% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on XRN shares. Zacks Research raised Global Medical REIT to a “hold” rating in a research report on Wednesday, July 22nd. Raymond James Financial assumed coverage on Global Medical REIT in a research report on Wednesday, June 17th. They set a “market perform” rating on the stock. Citizens Jmp upped their price target on Global Medical REIT from $40.00 to $42.00 and gave the stock a “market outperform” rating in a research note on Tuesday, May 26th. Weiss Ratings downgraded Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, July 30th. Finally, Wall Street Zen lowered Global Medical REIT from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th. Two equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Global Medical REIT currently has an average rating of “Hold” and an average price target of $40.25.

Key Stories Impacting Global Medical REIT

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: Director Charles Fitzgerald purchased 14,000 shares for approximately $500,920 at an average price of $35.78, increasing his direct ownership by 11.21%. This followed his purchase of another 27,600 shares, worth about $991,944, on August 10. SEC insider purchase filing
• Positive Sentiment: CEO Mark Okey Decker Jr. bought 8,000 shares for $287,040 on August 10 and an additional 550 shares for $19,800 on August 11. The purchases increased his holdings by 13.38% and 0.81%, respectively, signaling management confidence in the company’s valuation and outlook. CEO insider buying report
• Positive Sentiment: Global Medical REIT reported quarterly earnings per share of $4.78, exceeding the $0.83 consensus estimate by $3.95, with revenue of $39.75 million. The company posted a 36.82% net margin and 13.74% return on equity, while analysts expect full-year EPS of $3.06.
• Positive Sentiment: Some analysts remain constructive: Citizens JMP raised its price target to $42 from $40 and maintained an outperform rating. The average analyst price target is $40.25, above the recent trading level.
• Neutral Sentiment: Institutional ownership remains substantial at 57.52%. Invesco increased its position, and several other investment firms recently initiated or expanded holdings, providing some support from professional investors.
• Negative Sentiment: Analyst sentiment is mixed, with an overall “Hold” rating. Compass Point cut its price target to $38 from $50, Wall Street Zen downgraded the stock to “Sell,” and Raymond James initiated coverage at “Market Perform.”
• Negative Sentiment: The REIT carries meaningful leverage, with a debt-to-equity ratio of 1.68 and current and quick ratios of 0.68, factors that could limit financial flexibility if interest rates or property-market conditions worsen.

Global Medical REIT Company Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.